Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

Article  PubMed  Google Scholar 

Nellore J, Narayan AS, Sunkar S, et al. Circulating biomarkers for the early diagnosis of gastrointestinal cancers. Crit Rev Oncog. 2020;25:335–54.

Article  PubMed  Google Scholar 

Udomprasert A, Kangsamaksin T. DNA origami applications in cancer therapy. Cancer Sci. 2017;108:1535–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bordry N, Astaras C, Ongaro M, et al. Recent advances in gastrointestinal cancers. World J Gastroenterol. 2021;27:4493–503.

Article  PubMed  PubMed Central  Google Scholar 

Pullmer R, Linden W, Rnic K, et al. Measuring symptoms in gastrointestinal cancer: a systematic review of assessment instruments. Support Care Cancer. 2014;22:2941–55.

Article  PubMed  Google Scholar 

Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489–95.

Article  PubMed  Google Scholar 

Martin L, Senesse P, Gioulbasanis I, et al. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2015;33:90–9.

Article  PubMed  Google Scholar 

Argilés JM, Busquets S, Stemmler B, et al. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14:754–62.

Article  PubMed  Google Scholar 

Jafri SH, Previgliano C, Khandelwal K, et al. Cachexia index in advanced non-small-cell lung cancer patients. Clin Med Insights Oncol. 2015;9:87–93.

Article  PubMed  PubMed Central  Google Scholar 

Go SI, Park MJ, Lee GW. Clinical significance of the cachexia index in patients with small cell lung cancer. BMC Cancer. 2021;21:563.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Go SI, Park MJ, Park S, et al. Cachexia index as a potential biomarker for cancer cachexia and a prognostic indicator in diffuse large B-cell lymphoma. J Cachexia Sarcopenia Muscle. 2021;12:2211–9.

Article  PubMed  PubMed Central  Google Scholar 

Takahashi K, Masuda T, Ishikawa Y, et al. A novel frailty grade combined with cachexia index and osteopenia in esophagectomy. World J Surg. 2023;47:1503–11.

Article  PubMed  Google Scholar 

Nakashima K, Haruki K, Kamada T, et al. Usefulness of the cachexia index as a prognostic indicator for patients with gastric cancer. Ann Gastroenterol Surg. 2023;7:733–40.

Article  PubMed  PubMed Central  Google Scholar 

Gong C, Wan Q, Zhao R, et al. Cachexia index as a prognostic indicator in patients with gastric cancer: a retrospective study. Cancers (Basel). 2022;14.

Kamada T, Haruki K, Nakashima K, et al. Prognostic significance of the cachexia index in patients with stage I-III colorectal cancer who underwent laparoscopic surgery. Surg Today. 2023;53:1064–72.

Article  CAS  PubMed  Google Scholar 

Wan Q, Yuan Q, Zhao R, et al. Prognostic value of cachexia index in patients with colorectal cancer: a retrospective study. Front Oncol. 2022;12:984459.

Article  PubMed  PubMed Central  Google Scholar 

Akaoka M, Haruki K, Taniai T, et al. Clinical significance of cachexia index in patients with hepatocellular carcinoma after hepatic resection. Surg Oncol. 2022;45:101881.

Article  PubMed  Google Scholar 

Goh MJ, Kang W, Jeong WK, et al. Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy. Sci Rep. 2022;12:7647.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamura R, Haruki K, Shirai Y, et al. Preoperative cachexia index can predict the prognosis of extrahepatic biliary tract cancer after resection. Surg Oncol. 2022;44:101825.

Article  PubMed  Google Scholar 

Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:e1000100.

Article  PubMed  PubMed Central  Google Scholar 

Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.

Article  PubMed  Google Scholar 

Deeks JJ, Dinnes J, D'Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7:iii-x, 1–173

Altman DG, Bland JM. How to obtain the confidence interval from a P value. BMJ. 2011;343:d2090.

Article  PubMed  Google Scholar 

Altman DG, Bland JM. How to obtain the P value from a confidence interval. BMJ. 2011;343:d2304.

Article  PubMed  Google Scholar 

DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105–14.

Article  PubMed  Google Scholar 

Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses Bmj. 2003;327:557–60.

PubMed  Google Scholar 

Kanejima Y, Shimogai T, Kitamura M, et al. Effect of early mobilization on physical function in patients after cardiac surgery: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;17.

Komatsu H, Onoguchi G, Jerotic S, et al. Retinal layers and associated clinical factors in schizophrenia spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2022;27:3592–616.

Article  PubMed  Google Scholar 

Kuwada K, Kuroda S, Kikuchi S, et al. Clinical impact of sarcopenia on gastric cancer. Anticancer Res. 2019;39:2241–9.

Article  PubMed  Google Scholar 

Ouyang X, Dang Y, Zhang F, et al. Low serum albumin correlates with poor survival in gastric cancer patients. Clin Lab. 2018;64:239–45.

Article  CAS  PubMed  Google Scholar 

Qian C, Cai R, Zhang W, et al. Neutrophil-lymphocyte ratio and circulating tumor cells counts predict prognosis in gastrointestinal cancer patients. Front Oncol. 2021;11:710704.

Article  PubMed  PubMed Central  Google Scholar 

Anderson LJ, Albrecht ED, Garcia JM. Update on management of cancer-related cachexia. Curr Oncol Rep. 2017;19:3.

Article  PubMed  Google Scholar 

Ábrigo J, Elorza AA, Riedel CA, et al. Role of oxidative stress as key regulator of muscle wasting during cachexia. Oxid Med Cell Longev. 2018;2018:2063179.

Article  PubMed  PubMed Central  Google Scholar 

Ni J, Zhang L. Cancer cachexia: definition, staging, and emerging treatments. Cancer Manag Res. 2020;12:5597–605.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Narsale AA, Carson JA. Role of interleukin-6 in cachexia: therapeutic implications. Curr Opin Support Palliat Care. 2014;8:321–7.

Article  PubMed  PubMed Central  Google Scholar 

Camarero González E, Muñoz Leira V, Iglesias Guerrero M, et al. Protein-energy malnutrition: its effects on 4 metabolic parameters. Nutr Hosp. 1995;10:158–60.

PubMed  Google Scholar 

Rupert JE, Narasimhan A, Jengelley DHA, et al. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. J Exp Med. 2021;218.

Lin J, Zhang W, Huang Y, et al. Sarcopenia is associated with the neutrophil/lymphocyte and platelet/lymphocyte ratios in operable gastric cancer patients: a prospective study. Cancer Manag Res. 2018;10:4935–44.

Article  PubMed  PubMed Central  Google Scholar 

Temel JS, Abernethy AP, Currow DC, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016;17:519–31.

Article  CAS  PubMed  Google Scholar 

Crawford J. Clinical results in cachexia therapeutics. Curr Opin Clin Nutr Metab Care. 2016;19:199–204.

CAS  PubMed  Google Scholar 

Takiguchi S, Murakami K, Yanagimoto Y, et al. Clinical application of ghrelin in the field of surgery. Surg Today. 2015;45:801–7.

Article  CAS  PubMed  Google Scholar